• COVID-19
  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • Artificial Intelligence
    • Blockchain
    • Mobile Health
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage

Why A Patient-First Strategy for Specialty Rx Pharmacists Is Critical to Optimize Outcomes

by Dr. Brandon Salke, PHARM.D, Pharmacist-in-charge, Optime Care 01/08/2021 Leave a Comment

Patient-First Strategy: Uses Specialty Rx Pharmacists to Maximize Orphan and Rare Disease Management, Optimize Patient Journey and Outcomes

Dr. Brandon Salke, PHARM.D, Pharmacist-in-charge, Optime Care One of the biggest challenges for biopharmaceutical companies of rare and orphan disease patient populations is optimizing disease management in a way that enhances the patient journey and improves outcomes. As these companies seek innovative solution partners, a patient-first approach that offers specialty Rx pharmacist expertise is critical for securing insurance coverage, coordinating care, ensuring compliance, and, ultimately,
Read More

[ultimatesocial networks="facebook,twitter,google,linkedin,mail" url="" custom_class="us-posts-bottom" align="left" count="false"]

OurCrowd Launches $100M Pandemic Innovation Fund to Invest in Companies on Front Lines of COVID-19

by Fred Pennic 06/02/2020 Leave a Comment

OurCrowd Launches $100M Pandemic Fund to Target Solutions for COVID-19

What You Should Know: - Israeli venture capital platform OurCrowd launches $100M Pandemic Fund to invest in companies on the front lines of COVID-19. - The fund plans to raise $100M to invest in 15-20 companies focused on prevention & containment, treatment & healing, and community & disruption mitigation technology solutions to combat current and future pandemic. OurCrowd, a Jerusalem, Israel-based crowdfunded-venture investment platform, today announced the launch
Read More

[ultimatesocial networks="facebook,twitter,google,linkedin,mail" url="" custom_class="us-posts-bottom" align="left" count="false"]

Corrona Acquires Patient Experience Company HealthiVibe

by Fred Pennic 12/10/2019 Leave a Comment

Corrona Acquires Patient Experience Company HealthiVibe

- Corrona acquires patient experience company HealthiVibe to further expand its presence in the patient experience marketplace. - HealthiVibe uses a systematic, evidence-based process to help pharmaceutical clients spearhead patient engagement initiatives at every stage of the product lifecycle.Corrona, LLC, a provider of real-world observational and syndicated registry data, announced today that it has acquired HealthiVibe, LLC, an Arlington, VA-based patient experience company. Financial
Read More

[ultimatesocial networks="facebook,twitter,google,linkedin,mail" url="" custom_class="us-posts-bottom" align="left" count="false"]

ConvergeHEALTH by Deloitte Launches New Digital Health Ecosystem Platforms

by Jasmine Pennic 10/28/2019 Leave a Comment

ConvergeHEALTH by Deloitte Launches New Digital Health Ecosystem Platforms

- ConvergeHEALTH MyPATH for Health and MyPATH for Connected Care help enhance the patient experience, improve adherence and generate a rich, longitudinal, real-world data set for insights.Today at HLTH 2019, ConvergeHEALTH by Deloitte announced the launch of a robust platform for the healthcare ecosystem that supports two critically important patient journeys. MyPATH for Health and MyPATH for Connected Care work together to connect and support patients and their care teams across the patient
Read More

[ultimatesocial networks="facebook,twitter,google,linkedin,mail" url="" custom_class="us-posts-bottom" align="left" count="false"]

MyHealthTeams Lands $9.44M to Expand Social Networks for Chronic Condition Communities

by Jasmine Pennic 08/15/2019 Leave a Comment

MyHealthTeams Raises $9.44 Million

MyHealthTeams Co-founders Eric Peacock and Mary Ray MyHealthTeams, a San Francisco, CA-based creator of the largest and fastest-growing social networks for people facing chronic health conditions raised $9.44 million in a Series B financing round led by strategic investor UCB, a global biopharmaceutical company. This financing brings total investment in MyHealthTeams to $26.84M, building on the company's Seed and Series A1, A2 and A3 rounds. Existing investors including Adams Street Partners,
Read More

[ultimatesocial networks="facebook,twitter,google,linkedin,mail" url="" custom_class="us-posts-bottom" align="left" count="false"]

IBM, KPMG, Merck and Walmart to Launch FDA Blockchain Pilot Program

by Fred Pennic 06/13/2019 Leave a Comment

FDA Approves Blockchain/IoT Pilot to Track Specialty Prescription Drugs Across 3 States Blockchain in Healthcare_Next Stop for Data-driven Healthcare: Blockchain

IBM, KPMG, Merck, and Walmart today announced that the companies have been selected by the United States Food and Drug Administration (FDA) to be included in a blockchain pilot program in support of the U.S. Drug Supply Chain Security Act (DSCSA) that addresses requirements to identify, track and trace prescription medicines and vaccines distributed within the United States.Pilot Program OverviewThe FDA pilot program is intended to evaluate the use of blockchain technology to assist drug supply
Read More

[ultimatesocial networks="facebook,twitter,google,linkedin,mail" url="" custom_class="us-posts-bottom" align="left" count="false"]

Biofourmis Lands $35M for AI-Powered Digital Therapeutics Platform

by Jasmine Pennic 05/21/2019 Leave a Comment

Biofourmis Lands $35M for AI-Powered Digital Therapeutics Platform

Biofourmis, a Boston, MA-based digital therapeutics platform, today announced that it has raised $35 million in Series B funding led by Sequoia Capital/Sequoia India and co-led by Mass Mutual. The latest funding round will enable the company to advance its proprietary artificialintelligence (AI)-powered digital therapeutics platform and pipeline that treats and manages a range of complex chronic conditions.Digital Therapeutics is Redefining The Healthcare Value ChainFounded in 2015, Biofourmis
Read More

[ultimatesocial networks="facebook,twitter,google,linkedin,mail" url="" custom_class="us-posts-bottom" align="left" count="false"]

Clinical Operations Makes Highest Use of Artificial Intelligence, Tufts Study Finds

by Fred Pennic 05/07/2019 Leave a Comment

Clinical Operations Makes Highest Use of Artificial Intelligence, Tufts Study Finds

Clinical operations function makes the highest use of artificial intelligence (AI) (61%), followed by pharmacovigilance/safety/risk management (57%), and information technology (IT) (55%), according to an analysis recently completed by the Tufts Center for the Study of Drug Development. The analysis, summarized in the May/June Tufts CSDD Impact Report, reveals the pharmaceutical industry is adopting artificial intelligence (AI) on numerous fronts, from discovery and clinical development to risk
Read More

[ultimatesocial networks="facebook,twitter,google,linkedin,mail" url="" custom_class="us-posts-bottom" align="left" count="false"]

Pfizer & Concerto HealthAI Team Up on Precision Oncology Collaboration

by Jasmine Pennic 04/09/2019 Leave a Comment

Concerto HealthAI

Concerto HealthAI announced a deal with Pfizer, through which Pfizer will harness Concerto HealthAI’s eurekaHealth AI platform and real-world data (RWD) to help identify new and more precise treatment options as well as accelerate completion times for various outcomes studies. Concerto HealthAI is comprised of the leading healthcare data scientists, health economists, epidemiologists, and AI software engineers to advance flexible and increasingly enterprise grade solutions for advancing RWE into
Read More

[ultimatesocial networks="facebook,twitter,google,linkedin,mail" url="" custom_class="us-posts-bottom" align="left" count="false"]

RDMD Lands $3M to Drive Patient-Accelerated Drug Development in Rare Diseases

by Jasmine Pennic 08/21/2018 Leave a Comment

RDMD Lands $3M to Drive Patient-Accelerated Drug Development in Rare Diseases

San Francisco-based RDMD, a biopharma startup dedicated to accelerating research for patients with rare diseases, announced its $3 million seed financing backed by Lux Capital and Village Global, whose network of backers include Bill Gates, Mark Zuckerberg, Jeff Bezos, and Reid Hoffman. RDMD has developed a technology platform that generates deep data insights to accelerate rare disease research and drug development, as well as a patient application that empowers patients and families to get
Read More

[ultimatesocial networks="facebook,twitter,google,linkedin,mail" url="" custom_class="us-posts-bottom" align="left" count="false"]
  • 1
  • 2
  • Next Page

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Most Read

  • CVS Health Launches Senior Medical Alert System, Symphony CVS Health Launches Senior Medical Alert System, Symphony
  • 30 Executives Share Top Healthcare Predictions & Trends to Watch in 2021 30 Executives Share Top Healthcare Predictions & Trends to Watch in 2021
  • 20 COVID-19 Predictions and Trends for 2021 - Executive Roundup 20 COVID-19 Predictions and Trends for 2021 – Executive Roundup
  • 20 COVID-19 Predictions and Trends for 2021 - Executive Roundup MEDITECH Launches Quick Vaccination Solution to Streamline COVID-19 Vaccination Process
  • ONC Issues First Health IT Standards Bulletin Discussing USCDI & SVAP ONC Issues First Health IT Standards Bulletin Discussing USCDI & SVAP
  • 16 COVID-19 Predictions and Trends for 2021 Executive Roundup 12-Available-COVID-19-Vaccine-Management-Solutions-to-Know-In-Depth-1 17 Recently Launched COVID-19 Vaccine Management Solutions to Know
  • COVID-19 Deferrals Lead to 3 Major Conditions Payers/Providers Must Address in 2021 COVID-19 Deferrals Lead to 3 Major Conditions Payers/Providers Must Address in 2021
  • FDA Approves COVID-19 Oral Fluid Test for Use Nationwide In-Depth: 32 FDA-Approved COVID-19 Testing Kits
  • FCC COVID-19 Telehealth Program Providers FCC Unveils 14 Initial Projects Selected for $100M Connected Care Pilot Program
  • 5G in Healthcare: 7 Advantages & Disadvantages for Providers to Know 5G in Healthcare: 7 Advantages & Disadvantages for Providers to Know

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • 2020 Editorial Calendar
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2021. HIT Consultant Media. All Rights Reserved. Privacy Policy |